Monopar Therapeutics (MNPR) recently saw its stock surge over 16.6% to $5.4 following a partnership with Alexion to develop a treatment for Wilson's disease, marking significant growth with a 167.19% increase over the past year despite reporting no revenues and a net loss of $0.10 per share.
Capri Holdings Shares Plunge: Capri and Tapestry $8.5B Merger Blocked Over Antitrust Issues
Tesla Shares Soar Despite Mixed Q3 Results, Cheaper EV Set for 2024 Production
As earnings season approaches, McDonald’s is expected to perform well due to its value-oriented initiatives, while Starbucks faces uncertainty amid a leadership transition, with both companies set to report earnings on October 29 and 30, respectively.
Maersk Raises 2024 Earnings Target After Strong Q3 Performance
Tesla Q3 Earnings Preview: Will Regulatory Credits Save the Day?
Lucid Group's shares dropped significantly after the company projected a wider-than-expected third-quarter loss and announced a public stock offering of nearly 262.5 million shares to raise approximately $1.67 billion, while ASML reported strong demand in the artificial intelligence sector but slower recovery in other areas of the semiconductor market.
Nestle India Shares Drop 2% Despite Positive Opening Post Q2 Results
NuScale Power Shares Surge to Record High, Gaining 183% in One Year
Dominion Energy has reported an 86% increase in earnings and a 10% rise in revenue, with analysts predicting continued EPS growth of 21% and 129% in the next two quarters, while its stock has surged over 50% in the past year, currently holding an RS Rating of 84.
